Immunohistochemical analysis of tumors also revealed a significant reduction in the percentage of proliferating cell nuclear antigen (PCNA)-positive cells after treatments, confirming that anti-HER2 phage-based vaccination is able to reduce BC cell proliferation (Figure 4). Here, PCNA is linked to breast cancer.